Synthesis and evaluation of sesquiterpene lactone inhibitors of phospholipase A2 from bothrops jararacussu

Several sesquiterpene lactone were synthesized and their inhibitive activities on phospholipase A2 (PLA2) from Bothrops jararacussu venom were evaluated. Compounds Lac01 and Lac02 were efficient against PLA2 edema-inducing, enzymatic and myotoxic activities and it reduces around 85% of myotoxicity and around 70% of edema-inducing activity. Lac05–Lac08 presented lower efficiency in inhibiting the biological activities studied and reduce the myotoxic and edema-inducing activities around only 15%. The enzymatic activity was significantly reduced. The values of inhibition constants (KI) for Lac01 and Lac02 were approximately 740 μM, and for compounds Lac05–Lac08 the inhibition constants were approximately 7.622–9.240 μM. The enzymatic kinetic studies show that the sesquiterpene lactones inhibit PLA2 in a non-competitive manner. Some aspects of the structure–activity relationships (topologic, molecular and electronic parameters) were obtained using ab initio quantum calculations and analyzed by chemometric methods (HCA and PCA). The quantum chemistry calculations show that compounds with a higher capacity of inhibiting PLA2 (Lac01–Lac04) present lower values of highest occupied molecular orbital (HOMO) energy and molecular volume (VOL) and bigger values of hydrophobicity (LogP). These results indicate some topologic aspects of the binding site of sesquiterpene lactone derivatives and PLA2571100108CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO - CNPQCOORDENAÇÃO DE APERFEIÇOAMENTO DE PESSOAL DE NÍVEL SUPERIOR - CAPESFUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE MINAS GERAIS - FAPEMIGFUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO - FAPESPnão temnão temnão temnão te

Synthesis And Evaluation Of Sesquiterpene Lactone Inhibitors Of Phospholipase A2 From Bothrops Jararacussu

Several sesquiterpene lactone were synthesized and their inhibitive activities on phospholipase A2 (PLA2) from Bothrops jararacussu venom were evaluated. Compounds Lac01 and Lac02 were efficient against PLA2 edema-inducing, enzymatic and myotoxic activities and it reduces around 85% of myotoxicity and around 70% of edema-inducing activity. Lac05-Lac08 presented lower efficiency in inhibiting the biological activities studied and reduce the myotoxic and edema-inducing activities around only 15%. The enzymatic activity was significantly reduced. The values of inhibition constants (KI) for Lac01 and Lac02 were approximately 740 μM, and for compounds Lac05-Lac08 the inhibition constants were approximately 7.622-9.240 μM. The enzymatic kinetic studies show that the sesquiterpene lactones inhibit PLA2 in a non-competitive manner. Some aspects of the structure-activity relationships (topologic, molecular and electronic parameters) were obtained using ab initio quantum calculations and analyzed by chemometric methods (HCA and PCA). The quantum chemistry calculations show that compounds with a higher capacity of inhibiting PLA2 (Lac01-Lac04) present lower values of highest occupied molecular orbital (HOMO) energy and molecular volume (VOL) and bigger values of hydrophobicity (LogP). These results indicate some topologic aspects of the binding site of sesquiterpene lactone derivatives and PLA2. © 2010 Elsevier Ltd.571100108Arantes, F.F.P., Barbosa, L.C.B., de Alvarenga, E.S., Demuner, A.J., Bezerra, D.P., Ferreira, J.R.O., Costa-Lotufo, L.V., Moraes, M.O., Synthesis and cytotoxic activity of α-santonin derivatives (2009) Eur. J. Med. Chem., 44, pp. 3739-3745Balsinde, J., Dennis, E.A., Bromoenol lactone inhibits magnesium-dependent phosphatidate phosphohydrolase and blocks triacylglycerol biosynthesis in mouse P388D1 macrophages (1996) J. Biol. Chem., 271, pp. 31937-31941Balsinde, J., Winstead, M.V., Dennis, E.A., Phospholipase A2 regulation of arachidonic acid mobilization (2002) FEBS. Lett., 531, pp. 2-6Beebe, K.R., Pell, R.J., (1988) In Chemometrics: A Practical Guide, , Wiley-Interscience, M.B. Seasholtz (Ed.)Binisti, C., Touboul, E., Mounier, C., Heymans, F., Bon, C., Godfroid, J.J., Structure-activity relationships in platelet activating factor. 9. From PAF-antagonism to PLA2 inhibition (1997) J. Lipid. Mediat. Cell. Signal., 15, pp. 125-144Binisti, C., Assogba, L., Touboul, E., Mounier, C., Huet, J., Ombetta, J., Dong, C.Z., Godfroid, J.J., Structure-activity relationships in platelet-activating factor (PAF). 11-From PAF-antagonism to phospholipase A2 inhibition: syntheses and structure-activity relationships in 1-arylsulfamido-2-alkylpiperazines (2001) Eur. J. Med. Chem., 36, pp. 809-828Calgarotto, A.K., Miotto, S., Honório, K.M., Da Silva, A.B.F., Marangoni, S., Silva, J.L., Comar, M., Da Silva, S.L., A multivariate study on flavonoid compounds scavenging the peroxynitrite free radical (2007) J. Mol. Struct. (Theochem), 808, pp. 25-33Calgarotto, A.K., Damico, D.C.S., Ponce-Soto, L.A., Baldasso, P.A., Da Silva, S.L., Souza, G.H.M.F., Eberlin, M.N., Marangoni, S., Biological and biochemical characterization of new basic phospholipase A(2) BmTX-I isolated from Bothrops moojeni snake venom (2008) Toxicon, 51, pp. 1509-1519Chandra, V., Kaur, P., Jasti, J., Betzel, C., Srinivasan, A., Singh, T.P., First structural evidence of a specific inhibition of phospholipase A2 by α-tocopherol (Vitamin E) and its implications in inflammation: crystal structure of the complex formed between phospholipase A2 and α-tocopherol at 1.8 A resolution (2002) J. Mol. Biol., 320, pp. 215-222Chandra, V., Jasti, J., Kaur, P., Srinivasan, A., Betzel, C., Singh, T.P., Structural basis of phospholipase A2 inhibition for the synthesis of prostaglandins by the plant alkaloid aristolochic acid from a 1.7 A crystal structure (2002) Biochemistry, 41, pp. 10914-10919Chattaraj, P.K., Lee, H., Parr, R.G., HSAB principle (1991) J. Am. Chem. Soc., 113, pp. 1855-1856Costa, M.C.A., Takahata, Y., Neolignan analogues tested against leishmaniasis. A study of structure-activity relationships and a proposal for the shape of the receptor cavity (2003) J. Mol. Struct. (Theochem), 625, pp. 257-263Da Silva, S.L., Silva, A., Honório, K.M., Marangoni, S., Toyama, M.H., Da Silva, A.B.F., The influence of electronic, steric and hydrophobic properties of flavonoid compounds in the inhibition of the xanthine oxidase (2004) J. Mol. Struct. (Theochem), 684, pp. 1-7Da Silva, S.L., Figueiredo, P.M.S., Yano, T., Chemotherapeutic potential of the volatile oils from Zanthoxylum rhoifolium Lam leaves (2006) Eur. J. Pharmacol., 576, pp. 180-188Da Silva, S.L., Figueiredo, P.M.S., Yano, T., Antibacterial and antifungal activities of volatile oils from Zanthoxylum rhoifolium leaves (2007) Pharm. Biol., 44, pp. 657-659Da Silva, S.L., Calgarotto, A.K., Chaar, J.S., Marangoni, S., Isolation and characterization of ellagic acid derivatives isolated from Casearia sylvestris SW aqueous extract with anti-PLA2 activity (2008) Toxicon, 52, pp. 655-666Da Silva, S.L., Comar, M., Oliveira, K.M.T., Chaar, J.S., Bezerra, E.R.M., Calgarotto, A.K., Veber, C.L., Marangoni, S., Molecular modeling of the inhibition of enzyme PLA(2) from snake venom by dipyrone and 1-phenyl-3-methyl-5-pyrazolone (2008) Int. J. Quantum. Chem., 108, pp. 2576-2585Da Silva, S.L., Calgarotto, A.K., Maso, V., Damico, D.C.S., Baldasso, P.A., Veber, C.L., Villar, J.A.F.P., Marangoni, S., Molecular modeling and inhibition of phospholipase A2 by polyhydroxy phenolic compounds (2009) Eur. J. Med. Chem., 44, pp. 312-321De Alvarenga, E.S., Barbosa, L.C.A., Saliba, W., Arantes, F.F.P., Demuner, A.J., Síntese e avaliação da atividade fitotóxica de derivadosda α-Santonina (2009) Quim. Nova., 32, pp. 401-406Dentan, C., Tselepis, A.D., Chapman, M.J., Ninio, E., Pefabloc, 4-[2-aminoethyl] benzenesulfonyl fluoride, is a new, potent nontoxic and irreversible inhibitor of PAF-degrading acetylhydrolase (1996) Biochim. Biophys. Acta., 1299, pp. 353-357Diogo, L.C., Fernandes, R.S., Marcussi, S., Menaldo, D.L., Roberto, P.G., Matrangulo, P.V.F., Pereira, P.S., Lourenço, M.V., Inhibition of snake venoms and phospholipases A2 by extracts from native and genetically modified eclipta alba: isolation of active coumestans (2009) Basic Clin. Pharmacol. Toxicol., 104, pp. 293-299Dragon Molecular Descriptors Analysis for Windows, version 5.0, Talete srl, Milano, ItalyFunk, C.D., Prostaglandins and leukotrienes: advances in eicosanoid biology (2001) Science, 294, pp. 1871-1875Gaussian03 Software- Gaussian Inc., 340 Quinnipiac Street, Bldg 40 Wallingford, CT 06492 U.S.AGutiérrez, J.M., Comprendiendo los venenos de serpientes: 50 Anos de investigaciones en Amećrica Latina (2002) Rev. Biol. Trop., 50, pp. 377-394Hariharan, P.C., Pople, J.A., The influence of polarization functions on molecular orbital hydrogenation energies (1973) Theor. Chim. Acta., 28, p. 213HyperChem, Release 7.51 for Windows - Molecular Modeling System, Hypercube, USAJabeen, T., Singh, N., Singh, R.K., Sharma, S., Somvanshi, R.K., Dey, S., Singh, T.P., Non-steroidal anti-inflammatory drugs as potent inhibitors of phospholipase A2: structure of the complex of phospholipase A2 with niflumic acid at 2.5 A resolution (2005) Biochim. Biophys. Acta., 61, pp. 1579-1586Jenkins, C.M., Han, X., Mancuso, D.J., Gross, R.W., Identification of calcium-independent phospholipase A2 (iPLA2) beta, and not iPlA2 gamma, as the mediator of arginine vasopressin-induced arachidonic acid release in A-10 smooth muscle cells. Enantioselective mechanism-based discrimination of mammalian iPLA2s (2002) J. Biol. Chem., 277, pp. 32807-32814Kohn, W., Becke, A.D., Parr, R.G., Density functional theory of electronic structure (1996) J. Phys. Chem., 10, pp. 12974-12980Lättig, J., Böhl, M., Fischer, P., Tischer, S., Tietböhl, C., Menschikowski, M., Gutzeit, H.O., Pisabarro, T., Mechanism of inhibition of human secretory phospholipase A2 by flavonoids: rationale for lead design (2007) J. Comput. Aided. Mol. Des., 21, pp. 473-483Marcussi, S., Sant'Ana, C.D., Oliveira, C.Z., Rueda, A.Q., Menaldo, D.L., Beleboni, R.O., Stábeli, R.G., Soares, A.M., Snake venom phospholipase A2 (2007) Curr. Top. Med. Chem., 7, pp. 743-756Melo, P.A., Ownby, C.L., Ability of wedelolactone, heparin, and para-bromophenacyl bromide to antagonize the myotoxic effects of two crotaline venoms and their PLA2 myotoxins (1999) Toxicon, 37, pp. 199-215Melo, P.A., Pinheiro, D.A., Ricardo, H.D., Fernandes, F.F.A., Tomaz, M.A., El-Kik, C.Z., Strauch, M.A., Silva, A.J.M., Ability of a synthetic coumestan to antagonize Bothrops snake venom activities (2010) Toxicon, 55, pp. 488-496Parr, R.G., Pearson, R.G., Absolute hardness: companion parameter to absolute electronegativity (1983) J. Am. Chem. Soc., 105, pp. 7512-7516Parr, R.G., Szentpaly, L.V., Liu, S., Electrophilicity index (1999) J. Am. Chem. Soc., 121, pp. 1922-1924Perrin, D.D., Armarego, W.L.F., Perrin, D.R., (1980) Purification of Laboratory Chemicals, , Pergamon Press, LondonPirouette Multivariate Data Analysis for IBM PC Systems, Version 2.0, Infometrix, Seattle, WARomero, L., Marcussi, S., Marchi-Salvador, D.P., Silva, F.P., Fuly, A.L., Stábeli, R.G., Da Silva, S.L., Soares, A.M., Enzymatic and structural characterization of a basic phospholipase A2 from the sea anemone Condylactis gigantea (2010) Biochimie, 92, pp. 1063-1071Scott, P., Radom, L., Harmonic vibrational frequencies: an evaluation of Hartree-Fock, Møller-Plesset, quadratic configuration interaction, density functional theory, and semiempirical scale factors (1996) J. Phys. Chem., 100, p. 16502Sekar, K., Eswaramoorthy, S., Jain, M.K., Sundaralingam, M., Phospholipase A2 engineering. Structural and functional roles of the highly conserved active site residue aspartate-99 (1997) Biochemistry, 36, pp. 3104-3114Sinha, P., Boesch, S.E., Gu, C., Wheeler, R.A., Wilson, A.K., Harmonic vibrational frequencies: scaling factors for HF, B3LYP, and MP2 methods in combination with correlation consistent basis sets (2004) J. Phys. Chem. A., 108, pp. 9213-9217Soares, A.M., Giglio, J.R., Chemical modifications of phospholipases A2 from snake venoms: effects on catalytic and pharmacological properties (2003) Toxicon, 42, pp. 855-868Soares, A.M., Andrião-Escarso, S.H., Angulo, Y., Lomonte, B., Gutiérrez, J.M., Marangoni, S., Toyama, M.H., Giglio, J.R., Structural and functional characterization of myotoxin I, a Lys49 phospholipase A2 homologue from Bothrops moojeni (Caissaca) snake venom (2000) Arch. Biochem. Biophys., 373, pp. 7-15Soares, A.M., Fontes, M.R.M., Giglio, J.R., Phospholipases A2 myotoxins from Bothrops snake venoms: structure-function relationship (2004) Curr. Org. Chem., 8, pp. 1677-1690Song, H., Ramanadham, S., Bao, S., Fong-Fu Hsu, F.F., Turk, J., A bromoenol lactone suicide substrate inactivates group via phospholipase A2 by generating a diffiusible bromomethyl keto acid that alkylates cysteine thiols (2006) Biochemistry, 45, pp. 1061-1073Souza, A.D.L., Rodrigues-Filho, E., Souza, A.Q.L., Pereira, J.O., Calgarotto, A.K., Maso, V., Marangoni, S., Da Silva, S.L., Koningins, phospholipase A2 inhibitors from endophytic fungus Trichoderma koningii (2008) Toxicon, 51, pp. 240-250Ticli, F.K., Hage, L.I.S., Cambraia, R.S., Pereira, P.S., Magro, A.J., Fontes, M.R.M., Stábeli, R.G., Sampaio, S.V., Rosmarinic acid, a new snake venom phospholipase A2 inhibitor from Cordia verbenacea (Boraginaceae): antiserum action potentiation and molecular interaction (2005) Toxicon, 46, pp. 318-327Weber, K.C., Da Silva, S.L., Honório, K.M., Da Silva, A.B.F., Selection of quantum chemical descriptors by chemometric methods in the study of antioxidant activity of flavonoid compounds (2005) Int. J. Quantum. Chem., 103, pp. 731-737Yedgar, S., Lichtenberg, D., Schnitzer, E., Inhibition of phospholipase A2 as a therapeutic target (2000) Biochim. Biophys. Acta., 1488, pp. 182-187Yedgar, S., Cohen, Y., Shoseyov, D., Control of phospholipase A2 activities for the treatment of inflammatory conditions (2006) Biochim. Biophys. Acta., 1761, pp. 1373-138